|

Evolocumab Clinical Trials

4 actively recruiting trials across 1 location

▲ +1 trial since May 2026

Also known as: Repatha, Repatha®, repatha

Pipeline

Phase 2: 1Phase 4: 2

Top Sponsors

  • West China Hospital1
  • Brigham and Women's Hospital1
  • Beijing Luhe Hospital1
  • Beijing Inno Medicine Co., Ltd.1

Indications

  • Heart Disease4
  • Coronary Artery Disease2
  • Coronary Atherosclerotic Disease1
  • Stable Coronary Disease1
  • Coronary1

Other3 trials

CAPER-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS
Phase 4
Effects of PCSK-9 Inhibitor Treatment Prior to Undergoing Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction
N/A
YN001-004 in Patients With Coronary Atherosclerosis in Australia
Phase 2

Boston, Massachusetts1 trial

The Impact of Pcsk-9 Inhibition on PET CFR in Patients at High CV Risk

Brigham and Women's Hospital

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.